Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine)
| Brand name | Atgam |
|---|---|
| Active ingredient | Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine) |
| Strength | 50MG/ML |
| Dosage form | Injection |
| Route | Intravenous |
| Modality | Biologic |
| FDA approval | December 1996 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.